Literature DB >> 11145707

Hepatocyte growth factor is a regulator of monocyte-macrophage function.

F Galimi1, E Cottone, E Vigna, N Arena, C Boccaccio, S Giordano, L Naldini, P M Comoglio.   

Abstract

Hepatocyte growth factor (HGF) is a potent paracrine mediator of stromal/epithelial interactions, which is secreted as a matrix-associated inactive precursor (pro-HGF) and locally activated by tightly controlled urokinase cleavage. It induces proliferation and motility in epithelial and endothelial cells, and plays a role in physiological and pathological processes involving invasive cell growth, such as angiogenesis and parenchymal regeneration. We now report that HGF induces directional migration and cytokine secretion in human monocytes. Monocyte activation by endotoxin and IL-1beta results in the up-regulation of the HGF receptor expression and in the induction of cell-associated pro-HGF convertase activity, thus enhancing cell responsiveness to the factor. Furthermore, we provide evidence for the secretion of biologically active HGF by activated monocytes, implying an autocrine stimulation. Altogether, these data indicate that monocyte function is modulated by HGF in a paracrine/autocrine manner, and provide a new link between stromal environment and mononuclear phagocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145707     DOI: 10.4049/jimmunol.166.2.1241

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.

Authors:  Paolo Giannoni; Gabriella Pietra; Giorgia Travaini; Rodolfo Quarto; Genti Shyti; Roberto Benelli; Laura Ottaggio; Maria Cristina Mingari; Simona Zupo; Giovanna Cutrona; Ivana Pierri; Enrico Balleari; Alessandra Pattarozzi; Marco Calvaruso; Claudio Tripodo; Manlio Ferrarini; Daniela de Totero
Journal:  Haematologica       Date:  2014-02-21       Impact factor: 9.941

2.  Phenotypic differences in early outgrowth angiogenic cells based on in vitro cultivation.

Authors:  Tyler D Bammert; Collin A Beckstrom; Grace Lincenberg; Jamie G Hijmans; Jared J Greiner; Natalia G Rocha
Journal:  Cytotechnology       Date:  2019-02-12       Impact factor: 2.058

3.  Hepatocyte Growth Factor Suppresses Inflammation and Promotes Epithelium Repair in Corneal Injury.

Authors:  Masahiro Omoto; Kunal Suri; Afsaneh Amouzegar; Mingshun Li; Kishore R Katikireddy; Sharad K Mittal; Sunil K Chauhan
Journal:  Mol Ther       Date:  2017-05-11       Impact factor: 11.454

Review 4.  Is Immune Modulation the Mechanism Underlying the Beneficial Effects of Amniotic Cells and Their Derivatives in Regenerative Medicine?

Authors:  Antonietta R Silini; Marta Magatti; Anna Cargnoni; Ornella Parolini
Journal:  Cell Transplant       Date:  2016-11-03       Impact factor: 4.064

5.  Macrophage-specific expression of urokinase-type plasminogen activator promotes skeletal muscle regeneration.

Authors:  Margaret L Novak; Scott C Bryer; Ming Cheng; Mai-Huong Nguyen; Kevin L Conley; Andrew K Cunningham; Bing Xue; Thomas H Sisson; Jae-Sung You; Troy A Hornberger; Timothy J Koh
Journal:  J Immunol       Date:  2011-06-27       Impact factor: 5.422

Review 6.  Carrion's Disease: the Sound of Silence.

Authors:  Cláudia Gomes; Joaquim Ruiz
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

7.  Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent.

Authors:  Wendy M Mars; Minji Jo; Steven L Gonias
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

8.  Association of hepatocyte-derived growth factor receptor/caudal type homeobox 2 co-expression with mucosal regeneration in active ulcerative colitis.

Authors:  Ferenc Sipos; Miklós Constantinovits; Gábor Valcz; Zsolt Tulassay; Györgyi Műzes
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

Review 9.  Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.

Authors:  V Finisguerra; H Prenen; M Mazzone
Journal:  Oncogene       Date:  2016-03-21       Impact factor: 9.867

10.  Co-targeting c-Met and COX-2 leads to enhanced inhibition of lung tumorigenesis in a murine model with heightened airway HGF.

Authors:  Laura P Stabile; Mary E Rothstein; Christopher T Gubish; Diana E Cunningham; Nathan Lee; Jill M Siegfried
Journal:  J Thorac Oncol       Date:  2014-09       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.